Masimo (NASDAQ:MASI) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Masimo Co. (NASDAQ:MASI) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $138.22 and traded as high as $169.66. Masimo shares last traded at $168.80, with a volume of 634,326 shares traded.

Wall Street Analyst Weigh In

MASI has been the subject of a number of recent research reports. BTIG Research increased their target price on Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Wednesday, November 6th. Raymond James raised their price target on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a report on Friday, December 27th. Piper Sandler boosted their price objective on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, December 18th. Finally, Stifel Nicolaus restated a “buy” rating and set a $190.00 target price (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $179.67.

Masimo Trading Down 1.4 %

The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a market cap of $8.91 billion, a P/E ratio of 114.77 and a beta of 1.01. The business has a fifty day simple moving average of $168.12 and a 200 day simple moving average of $138.69.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $504.60 million during the quarter, compared to the consensus estimate of $502.87 million. During the same quarter in the previous year, the company posted $0.63 earnings per share. The firm’s revenue was up 5.4% on a year-over-year basis. Analysts anticipate that Masimo Co. will post 4.03 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Texas Permanent School Fund Corp increased its stake in shares of Masimo by 12.0% in the second quarter. Texas Permanent School Fund Corp now owns 43,500 shares of the medical equipment provider’s stock valued at $5,478,000 after purchasing an additional 4,653 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Masimo in the 2nd quarter worth approximately $109,000. American Century Companies Inc. increased its stake in shares of Masimo by 18.6% during the second quarter. American Century Companies Inc. now owns 10,671 shares of the medical equipment provider’s stock valued at $1,344,000 after acquiring an additional 1,671 shares during the period. Qsemble Capital Management LP raised its holdings in Masimo by 66.1% during the second quarter. Qsemble Capital Management LP now owns 2,771 shares of the medical equipment provider’s stock worth $349,000 after purchasing an additional 1,103 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Masimo by 45.9% in the second quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider’s stock worth $66,201,000 after purchasing an additional 165,257 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.